FDA study links high consumer CBD doses to liver enzyme elevations
- medicalxpress.com language
- 2025-07-10 21:59 event
- 4 days ago schedule

Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased liver cancer risk, based on a population-based analysis of more than 1.5 million women and a review of 23 previous studies.
University of Warwick researchers have led the development of a new AI tool that can help doctors make the difficult and high-stakes decision of whether to intubate a patient in acute respiratory failure.
Susan Monarez is one step closer to becoming the next director of the U.S. Centers for Disease Control and Prevention (CDC).
The life-saving impact of global vaccine stockpiles to address outbreaks of vaccine-preventable diseases has been demonstrated in new Burnet Institute research.
We've long known there's a link between alcohol and violence, but when it comes to homicide the stories behind the statistics are harder to grasp.
Some mammals are capable of hibernating during periods of low food availability in an effort to conserve energy and survive. While it is easy to understand why species have evolved this survival mechanism, exactly how these animals regulate their metabolism and body temperature remains a mystery.
Even four years after the start of the COVID-19 pandemic, California residents aren't living as long as they used to.
Most folks diagnosed with Lyme disease aren't getting the follow-up care they need, a new study says.
A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and SARS-CoV-2 infections may play a role in the pathogenesis of Alzheimer's disease.
FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may elevate liver enzymes in healthy adults.
Women now make up over half of medical students in Canada, but only one-third of practicing surgeons. A new study suggests part of the gap stems from gender norms embedded in workplace culture. The researchers at McGill University say subtle but persistent biases may be driving women out of the field.
Hair loss is one of the most feared and traumatic side effects of cancer chemotherapy treatment, both for patients themselves and their loved ones, as it can visibly represent the "face of cancer."
Adolescence is a crucial stage of human development. During this unstable period, teenagers experience numerous physical, emotional and social changes that can be extremely challenging. It is a time of identity construction, increased exposure to external pressures, and a search for autonomy. Without the right support, this can all take a significant emotional toll.
New research reveals that virtual maternity care during the COVID-19 pandemic may have driven increased use of subsequent care, raising overall maternity costs for the NHS.
Among the more than 100 types of human papillomavirus (HPV), at least 14 are considered as "high-risk" types which can cause (cervical) cancer. After breast cancer, cervical cancer is the most common cancer in Europe among women aged 15–44 years.
Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies to treat cancer.
An alternative diagnostic method could improve early detection and treatment of peripheral artery disease (PAD), according to a new study from the University of Surrey. PAD is a common condition affecting up to a quarter of adults that causes poor blood circulation to the legs and feet, which may result in pain, ulcers, and, most dangerously, in amputation. Often PAD is diagnosed too late.
Female sex hormones can significantly enhance the progression of the rare neurodegenerative eye disease retinitis pigmentosa (RP), according to a preclinical study by researchers at UT Southwestern Medical Center.
A global study led by researchers at the School of Clinical Sciences at Monash Health, Monash University, has found that clinical trials that share their raw data are significantly more likely to be trustworthy and well-conducted, raising fresh concerns about how evidence is selected and used in medical guidelines.